American Strategic Investment (NYC) Q3 2024 earnings summary

Executive summary

• Portfolio consists of seven Manhattan commercial properties totaling 1.2 million sq ft, with 85.8% occupancy and a weighted-average lease term of 5.9 years as of Q3 2024.

• Top 10 tenants are 81% investment grade or implied investment grade, with a weighted-average remaining lease term of up to 8 years, including government and core commercial tenants.

• Entered a definitive agreement to sell 9 Times Square for $63.5 million, with net proceeds of $13.5 million expected to close by January 2025; 123 William Street and 196 Orchard are actively marketed for sale.

• Three new leases signed in Q3 2024 totaling 24,081 sq ft and $1.4 million in annualized straight-line rent, supporting occupancy and rent growth.

• No dividends have been paid since June 2022, and there is no assurance of future dividends.

Financial highlights

• Q3 2024 revenue was $15.4 million, down from $16.0 million in Q3 2023; net loss attributable to common stockholders was $34.5 million, primarily due to $27.8 million in non-cash impairments.

• Adjusted EBITDA was $3.1 million, down from $3.4 million year-over-year; Cash NOI increased 3.8% year-over-year to $6.8 million.

• Operating expenses for Q3 2024 were $44.7 million, up from $20.7 million in Q3 2023, driven by impairment charges.

• Interest expense increased to $5.3 million in Q3 2024 from $4.7 million in Q3 2023.

• Cash and cash equivalents were $5.2 million as of September 30, 2024, with restricted cash of $10.5 million.

Outlook and guidance

• Proceeds from asset sales, including 9 Times Square, are expected to reduce leverage and be redeployed into higher-yielding investments, with a focus on diversification beyond Manhattan.

• Management anticipates continued portfolio diversification and value creation through strategic asset management and redeployment of capital.

• Capital expenditures for 2024 are expected to be lower than 2023, but may change based on management's assessment.